NYMC Faculty Publications
Clinicopathologic Consequences Following Discontinuation of Rifaximin in Patients with Sickle Cell Disease
DOI
10.1002/ajh.25798
Journal Title
American Journal of Hematology
First Page
151
Last Page
153
Document Type
Article
Publication Date
6-2020
Department
Medicine
Recommended Citation
Lim, S. H., & Dutta, D. (2020). Clinicopathologic Consequences Following Discontinuation of Rifaximin in Patients with Sickle Cell Disease. American Journal of Hematology, 95 (6), 151-153. https://doi.org/10.1002/ajh.25798
COinS
